Journal of Neurology

, Volume 263, Issue 3, pp 477–484 | Cite as

Long-term outcome after cerebral venous thrombosis: analysis of functional and vocational outcome, residual symptoms, and adverse events in 161 patients

  • Sini Hiltunen
  • Jukka Putaala
  • Elena Haapaniemi
  • Turgut Tatlisumak
Original Communication

Abstract

Cerebral venous thrombosis (CVT) affects mainly working-aged individuals. Functional recovery after CVT is generally considered good with about 3/4 of patients achieving short-term independence. However, vascular events, long-term functional outcome, and employment after CVT remain poorly investigated. We identified consecutive adult CVT patients treated at the Helsinki University Hospital (1987–2013) and invited them to a follow-up visit. Each clinical examination was combined with interview. We also recorded recurrent venous thromboembolism (VTE) and hemorrhagic events during follow-up and antithrombotic medication use. A modified Rankin Scale (mRS) served to assess functional outcome. Logistic regression served to identify independent factors associated with unemployment and functional recovery. Of the 195 patients identified, 21 died, 9 declined to participate, and 4 were excluded from the study. Thus, 161 patients (106 women) underwent an examination after a median of 39 months (interquartile range 14–95). VTE (one of which was CVT) occurred in 9 (6 %) patients, and severe hemorrhagic events in 10 (6 %). Functional outcome was good, with 84 % scoring 0–1 on the mRS; 42 % reported residual symptoms. Altogether, 91 (57 %) patients were employed. After adjusting for age and sex, a National Institutes of Health Stroke Scale score >2 at admission and low education level, associated with both unfavorable functional outcome and unemployment. Long-term functional outcome after CVT may appear good if measured with mRS, but patients often have residual symptoms and are frequently unable to return to their previous work.

Keywords

Cerebral venous thrombosis Sinus thrombosis Long-term outcome Anticoagulation Follow-up Vocational status 

Notes

Acknowledgments

We thank Marja Metso (RN) and Saija Eirola (RN) for their dedication and technical support.

Sources of funding

This project received funding from the Helsinki University Hospital Research Funds (TT) and the National Graduate School of Clinical Investigation (SH).

Compliance with ethical standards

Conflicts of interest

None.

Ethical standards

All human studies must state that they have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.

Supplementary material

415_2015_7996_MOESM1_ESM.pdf (322 kb)
Supplementary material 1 (PDF 321 kb)

References

  1. 1.
    Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT I (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 35(3):664–670CrossRefPubMedGoogle Scholar
  2. 2.
    Putaala J, Hiltunen S, Salonen O, Kaste M, Tatlisumak T (2010) Recanalization and its correlation to outcome after cerebral venous thrombosis. J Neurol Sci 292(1–2):11–15CrossRefPubMedGoogle Scholar
  3. 3.
    de Bruijn SF, de Haan RJ, Stam J (2001) Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For the cerebral venous sinus thrombosis study group. J Neurol Neurosurg Psychiatry 70(1):105–108CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Miranda B, Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Scoditti U, ISCVT I (2010) Venous thromboembolic events after cerebral vein thrombosis. Stroke 41(9):1901–1906CrossRefPubMedGoogle Scholar
  5. 5.
    Martinelli I, Bucciarelli P, Passamonti SM, Battaglioli T, Previtali E, Mannucci PM (2010) Long-term evaluation of the risk of recurrence after cerebral sinus-venous thrombosis. Circulation 121(25):2740–2746CrossRefPubMedGoogle Scholar
  6. 6.
    Gosk-Bierska I, Wysokinski W, Brown RD Jr, Karnicki K, Grill D, Wiste H, Wysokinska E, McBane RD (2006) Cerebral venous sinus thrombosis: incidence of venous thrombosis recurrence and survival. Neurology 67(5):814–819CrossRefPubMedGoogle Scholar
  7. 7.
    Ciron J, Godeneche G, Vandamme X, Rosier MP, Sharov I, Mathis S, Larrieu D, Neau JP (2013) Obstetrical outcome of young women with a past history of cerebral venous thrombosis. Cerebrovasc Dis 36(1):55–61CrossRefPubMedGoogle Scholar
  8. 8.
    Lamy C, Hamon JB, Coste J, Mas JL (2000) Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French study group on stroke in pregnancy. Neurology 55(2):269–274CrossRefPubMedGoogle Scholar
  9. 9.
    Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J, Cerebral Venous Thrombosis Portugese Collaborative Study Group (2002) Long-term prognosis of cerebral vein and dural sinus thrombosis. Results of the VENOPORT study. Cerebrovasc Dis 13(4):272–278CrossRefPubMedGoogle Scholar
  10. 10.
    Preter M, Tzourio C, Ameri A, Bousser MG (1996) Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke 27(2):243–246CrossRefPubMedGoogle Scholar
  11. 11.
    Strupp M, Covi M, Seelos K, Dichgans M, Brandt T (2002) Cerebral venous thrombosis: correlation between recanalization and clinical outcome—a long-term follow-up of 40 patients. J Neurol 249(8):1123–1124CrossRefPubMedGoogle Scholar
  12. 12.
    Breteau G, Mounier-Vehier F, Godefroy O, Gauvrit JY, Mackowiak-Cordoliani MA, Girot M, Bertheloot D, Henon H, Lucas C, Leclerc X, Fourrier F, Pruvo JP, Leys D (2003) Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol 250(1):29–35CrossRefPubMedGoogle Scholar
  13. 13.
    de Bruijn SF, Budde M, Teunisse S, de Haan RJ, Stam J (2000) Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology 54(8):1687–1689CrossRefPubMedGoogle Scholar
  14. 14.
    Buccino G, Scoditti U, Patteri I, Bertolino C, Mancia D (2003) Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis. Acta Neurol Scand 107(5):330–335CrossRefPubMedGoogle Scholar
  15. 15.
    Koopman K, Uyttenboogaart M, Vroomen PC, van der Meer J, De Keyser J, Luijckx GJ (2009) Long-term sequelae after cerebral venous thrombosis in functionally independent patients. J Stroke Cerebrovasc Dis 18(3):198–202CrossRefPubMedGoogle Scholar
  16. 16.
    Haghighi AB, Edgell RC, Cruz-Flores S, Feen E, Piriyawat P, Vora N, Callison RC, Alshekhlee A (2012) Mortality of cerebral venous-sinus thrombosis in a large national sample. Stroke 43(1):262–264CrossRefGoogle Scholar
  17. 17.
    Simes J, Becattini C, Agnelli G, Eikelboom JW, Kirby AC, Mister R, Prandoni P, Brighton TA, INSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism) (2014) Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration. Circulation 130(13):1062–1071CrossRefPubMedGoogle Scholar
  18. 18.
    Bugnicourt JM, Guegan-Massardier E, Roussel M, Martinaud O, Canaple S, Triquenot-Bagan A, Wallon D, Lamy C, Leclercq C, Hannequin D, Godefroy O (2013) Cognitive impairment after cerebral venous thrombosis: a two-center study. J Neurol 260(5):1324–1331CrossRefPubMedGoogle Scholar
  19. 19.
    Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7):864–870CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Sini Hiltunen
    • 1
    • 2
  • Jukka Putaala
    • 1
  • Elena Haapaniemi
    • 1
  • Turgut Tatlisumak
    • 1
    • 3
    • 4
  1. 1.Department of NeurologyHelsinki University HospitalHelsinkiFinland
  2. 2.National School of Clinical InvestigationHelsinkiFinland
  3. 3.Institute of Neuroscience and PhysiologySahlgrenska Academy at University of GothenburgGothenburgSweden
  4. 4.Department of NeurologySahlgrenska University HospitalGothenburgSweden

Personalised recommendations